New appointments at Syntaxin
This article was originally published in Scrip
Executive Summary
Syntaxin, a UK biotechnology company developing biopharmaceuticals that control cell secretion, has appointed Dr Melanie Lee chief executive officer, Dr Nigel Clark chief business officer and Dr Jon Court chief development officer. Dr Lee was formerly president of new medicines and executive vice-president of R&D at UCB, having served as R&D director at Celltech before its merger with UCB; Dr Clark previously served as vice-president of business development at Vernalis; and Dr Court was formerly founder and CEO of Fulcrum Pharma.